# FDA Inspection 1069118 - Nemours Alfred I. duPont Hospital for Children - September 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/nemours-alfred-i-dupont-hospital-for-children/42b9a91b-8d7d-4274-b933-a89f255b8c68
Source feed: FDA_Inspections

> FDA Inspection 1069118 for Nemours Alfred I. duPont Hospital for Children on September 17, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069118
- Company Name: Nemours Alfred I. duPont Hospital for Children
- Inspection Date: 2018-09-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1280525 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/nemours-alfred-i-dupont-hospital-for-children/80140d6c-7b38-43e8-84de-63129d553e6b)
- [FDA Inspection 1280525 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/nemours-alfred-i-dupont-hospital-for-children/b3278064-1cad-4eb9-ae12-57487f30e5d6)
- [FDA Inspection 967915 - 2016-03-31](https://www.keypedia.com/records/fda_inspections/nemours-alfred-i-dupont-hospital-for-children/1ad69c54-0033-4a92-8f1f-78ba00709c2f)
- [FDA Inspection 874287 - 2014-04-15](https://www.keypedia.com/records/fda_inspections/nemours-alfred-i-dupont-hospital-for-children/29601dc9-9d7b-4d7e-bdb9-279d366552ea)
- [FDA Inspection 776372 - 2012-04-05](https://www.keypedia.com/records/fda_inspections/nemours-alfred-i-dupont-hospital-for-children/54d3663a-1360-43da-96a4-1acc53519b2b)

Company: https://www.keypedia.com/companies/nemours-alfred-i-dupont-hospital-for-children/fefd4e17-c707-48c1-9d64-984f34ee8fb1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d